Prestige Consumer Healthcare Inc (PBH) Given Average Recommendation of “Hold” by Analysts

Prestige Consumer Healthcare Inc (PBH) Given Average Recommendation of “Hold” by Analysts

April 29, 2019 Off By administrator

Shares of Prestige Consumer Healthcare Inc (NYSE:PBH) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $57.88.

A number of equities research analysts recently weighed in on the stock. Zacks Investment Research raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a research report on Wednesday, January 2nd. Raymond James lowered shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 target price for the company. in a research note on Tuesday, January 15th. Royal Bank of Canada reissued a “buy” rating and set a $97.00 target price on shares of Prestige Consumer Healthcare in a research note on Friday, March 15th. Desjardins lowered shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 target price for the company. in a research note on Wednesday, February 13th. Finally, ValuEngine lowered shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research note on Thursday, January 10th.

NYSE PBH traded down $0.01 during midday trading on Monday, hitting $28.07. 20,580 shares of the company traded hands, compared to its average volume of 601,188. The company has a current ratio of 2.28, a quick ratio of 1.34 and a debt-to-equity ratio of 1.49. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The stock has a market capitalization of $1.45 billion, a PE ratio of 10.88, a price-to-earnings-growth ratio of 1.58 and a beta of 0.98.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.02. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The business had revenue of $241.40 million during the quarter, compared to the consensus estimate of $241.40 million. During the same quarter in the prior year, the firm earned $0.70 EPS. The company’s revenue for the quarter was down 10.8% compared to the same quarter last year. On average, equities analysts predict that Prestige Consumer Healthcare will post 2.77 earnings per share for the current fiscal year.

A number of institutional investors have recently bought and sold shares of PBH. Thrivent Financial for Lutherans lifted its stake in shares of Prestige Consumer Healthcare by 2.7% in the 4th quarter. Thrivent Financial for Lutherans now owns 13,137 shares…

(Excerpt) To read the full article , click here
Image credit: source